Uterine Serous Carcinoma
📧 Sign up to get email alerts when something new happens for Uterine Serous Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. [Phase 1]
A Phase 1 trial evaluating escalating doses of the investigational agent BMS-986463 to assess safety, tolerability, and early signals of act…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Azenosertib in Uterine Serous Carcinoma: Biomarker Study [Phase 2]
Phase 2 biomarker study of Azenosertib in uterine serous carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma [Phase 2]
A Phase II trial evaluating afatinib for persistent or recurrent HER2-positive uterine serous carcinoma, currently recruiting.